Načítá se...
Developing Insulin Delivery Devices with Glucose-Responsiveness
Individuals with Type 1 and advanced Type 2 diabetes require daily insulin therapy to maintain blood glucose levels in normoglycemic ranges to prevent associated morbidity and mortality. Optimal insulin delivery should offer both precise dosing in response to real-time blood glucose levels as well a...
Uloženo v:
| Vydáno v: | Trends Pharmacol Sci |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7758938/ https://ncbi.nlm.nih.gov/pubmed/33250274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2020.11.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|